Related Experiment Video
Updated: Jun 22, 2026

Zinc-finger Nuclease Enhanced Gene Targeting in Human Embryonic Stem Cells
Published on: August 23, 2014
Gene targeting: attention to detail
Bart Vanhaesebroeck1, Jennifer L Rohn, Michael D Waterfield
1Ludwig Institute for Cancer Research, London, United Kingdom.
Abstract:
When it comes to silencing genes in mice, not all approaches are equal. An example published in this issue of Cell (Patrucco et al., 2004) suggests that caution should be used when validating potential drug targets by genetic disruption.
Insights
Genetic disruption in mice requires careful validation for drug target development. Not all gene silencing methods are equally effective, impacting therapeutic strategies.
Area of Science:
- Genetics
- Pharmacology
- Molecular Biology
Background:
- Gene silencing is crucial for understanding gene function and developing therapeutics.
- Genetic disruption, including knockout and knockdown techniques, is a common method for gene silencing.
- Validating drug targets often involves assessing the effects of genetic manipulation.
Discussion:
- The study highlights that the efficacy of gene silencing varies depending on the approach used in mice.
- Researchers must exercise caution when interpreting results from genetic disruption experiments.
- The choice of gene silencing strategy can significantly influence the outcome of drug target validation.
Key Insights:
- Different gene silencing techniques yield varying results in mice.
- Genetic disruption is not always a reliable method for validating drug targets.
- Careful experimental design and validation are essential in genetic research.
Outlook:
- Future research should focus on developing standardized and reliable gene silencing methods.
- Improved validation strategies are needed for drug discovery pipelines.
- Understanding the nuances of gene silencing will advance therapeutic development.
Related Concept Videos
In-vitro Mutagenesis
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...

